| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.0569 | 13 |
| GSM780708 | Untreated after 4 days (C2_1) | 37.8986 | 2 |
| GSM780709 | Untreated after 4 days (C3_1) | 35.9705 | 1 |
| GSM780719 | Untreated after 4 days (C1_2) | 38.805 | 4 |
| GSM780720 | Untreated after 4 days (C2_2) | 37.111 | 2 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.3151 | 14 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 39.1084 | 4 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 40.7035 | 8 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 38.5284 | 3 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 41.9653 | 13 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.8927 | 27 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 41.6036 | 12 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.7776 | 16 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 37.9885 | 3 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.0904 | 23 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.9353 | 27 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 46.172 | 33 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 36.6556 | 1 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 39.7213 | 6 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 38.823 | 4 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 36.7914 | 1 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 41.5637 | 11 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 37.6156 | 2 |